Nadya Jammal
5PUBLICATIONS
16CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jun 17, 2022
Blinatumomab is associated with favorable outcomes in patients with B-cell lineage acute lymphoblastic leukemia and positive measurable residual disease at a threshold of 10-4 and higher.Elias J Jabbour, Nicholas J Short, Nitin Jain
|Apr 01, 2021
Duration of cytopenias with concomitant venetoclax and azole antifungals in acute myeloid leukemia.Caitlin R Rausch, Courtney D DiNardo, Abhishek Maiti
|Jan 15, 2021
Phase 2 study of lenalidomide maintenance for patients with high-risk acute myeloid leukemia in remission.Iman Abou Dalle, Hagop M Kantarjian, Farhad Ravandi
|Nov 09, 2020
Cell cycle inhibitors for the treatment of acute myeloid leukemia: a review of phase 2 & 3 clinical trials.Nadya Jammal, Caitlin R Rausch, Tapan M Kadia
|Jun 20, 2019
Outcomes of combination therapy with tyrosine kinase inhibitors and immune checkpoint inhibitors in metastatic renal cell carcinoma - A retrospective study.Nadya Jammal, Eva Pan, Michael Hurwitz
Pageof 1
Frequent Collaborators
3 joint publications
Tapan M Kadia
2 joint publications
Courtney D DiNardo
2 joint publications
Naval G Daver
2 joint publications
Koji Sasaki
2 joint publications
Nicholas J Short
2 joint publications
Hagop M Kantarjian
2 joint publications
Guillermo Garcia-Manero
2 joint publications
Elias Jabbour
1 joint publications
Caitlin R Rausch
1 joint publications
Jing Ning
